New GSK To Leave Flagship HQ After Consumer Health Split
Will Depart Landmark HQ
Company follows US office downsizing with similar plans for its global headquarters, once consumer health spin-out is complete in 2022.
You may also be interested in...
Another Activist Investor Joins Calls For GSK Leadership Review
A second activist investor has called for GSK to consider replacing Emma Walmsley as CEO
, and has underlined competitive threats to a key pipeline candidate.
‘New GSK’ Still Has Some Convincing To Do
Once the consumer health division is spun out in mid-2022, a leaner ‘new GSK’ must set about delivering on its promising pipeline – and proving its skeptics wrong.
Allogene May Have Cracked The Off-The-Shelf CAR-T Problem
Allogeneic candidate’s durability is holding up thanks to a novel conditioning regimen, but Phase II data will be crucial test.